Vetter Opens Injectables Packaging Facility in Illinois
The first expansion of Ravensburg, Germany’s Vetter Pharma outside its home country is a 24,000-sq.-ft developmental facility in Skokie, IL. Vetter will handle preclinical through Phase IIb projects for syringes, vials and cartridges; Phase III production would continue in Ravensburg. The site is expected to be operational by the end of 2010 and will employ up to 60 workers.
Articles in this issue
FDA warns of enforcement impersonators preying on Internet pharmacy customers
J&J/McNeil widens a recall of contaminated Tylenol
Impax Labs Enjoys the Fruits of Its IBM Cognos Investment
Short Takes
Industry Tackles the New REMS Hurdle
Pharma Gets a 'Just in Time' Speedup With the Switch to Digital Printing
Cargo Theft Emerges as a New Biopharma Worry
Getting Value From End-of-Life-Cycle Pharmaceuticals
HDMA Analyzes Evolving Specialty Distribution Business
UPS and Genzyme Are About to Go Live on a California- and GS1-Compliant Track-and-Trace System
AMR Research Selects 'Healthcare Top 25' for Supply Chain Excellence
Cardinal Health Tailors Pharma Deliveries to High-Volume Mail-Order Pharmacies
UCB Offers Tailored Syringe for Rheumatoid Arthritis Patients
Botox Lawsuit Highlights Another Wrinkle for REMS
How to Ensure Successful Design and Implementation of Physician Segmentation
Recent Videos
Related Content
Touchlight, University of Nottingham Collaborate on Development of Zika Vaccine
August 21st 2024Article
Although it still has to undergo the preclinical and clinical trial process, the DNA vaccine—which could be created in as little as six weeks—does not require the cold chain storage that mRNA jabs often demand.
